Search Count: 4
 |
C-Terminal Bromodomain Of Human Brd2 With 1,3-Dimethyl-5-(1-((Tetrahydro-2H-Pyran-4-Yl)Methyl)-1H-Benzo[D]Imidazol-2-Yl)Pyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2023-10-18 Classification: TRANSCRIPTION Ligands: NUB, MES |
 |
C-Terminal Bromodomain Of Human Brd2 With (S)-5-(1-((1-Acetylpiperidin-3-Yl)Methyl)-5-Bromo-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2023-10-18 Classification: TRANSCRIPTION Ligands: EDO, MES, I0U |
 |
N-Terminal Bromodomain Of Human Brd4 With (S)-5-(1-((1-(1-Isopropylpiperidine-4-Carbonyl)Piperidin-3-Yl)Methyl)-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2023-10-18 Classification: TRANSCRIPTION Ligands: I0Z |
 |
Kinase Domain Mutant Of Human Itk In Complex With A Covalently-Binding Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.18 Å Release Date: 2013-08-21 Classification: Transferase/Transferase inhibitor Ligands: G5K, G6K, SO4, GOL |